Cytodyn Inc (CYDY)

[kgromax]

What is intriguing for the late Cytodyn form D filing is 2 things:

(1) The very next market day (Monday, Nov. 9th, 2020) after the private sale started,
the stock crashed by -20% with huge volumes.

(2) The following market day (Tuesday, Nov. 10th, 2020), it crashed again to a combined low of nearly -40%,
to stabilize and bounce slightly above the -40% discount price of the private sale

Remember, these days the private Cytodyn sale was still confidential (unknown) for shareholders. They were contemplating a -40% stock crash without any information about who could be causing that and why.

Huge volumes, not seen since last summer. And a clear low in the stock price, I bet many investors exited with signifiant losses (stop loss orders triggered).

These 2 events, the private sale and the stock crash, were so close in time and in price that it raises the question of their causality (or not). We don't know today if they were related or if that was a pure coincidence.

But we know SEC regulation forces the company to document such private sales (form D) within 15 calendar days. Precisely to ensure shareholders are properly informed of such material transactions and can adjust their decisions accordingly within a reasonable timeframe.

Yet the company did not follow this regulation. They filed the form D 39 days after, nearly 1 month and a half after the coincidence.

These are 2 key questions for the next company's conference call:
- Have they been informed of any relationship between these 2 events?
- Why have they decided to wait 39 days to file the form D?